Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial.
- 2022-01
- RCT
- Oxidative medicine and cellular longevity 2022(1)
- Mehrdokht Mazdeh
- Parnaz Abolfathi
- Maryam Sabetghadam
- Younes Mohammadi
- Maryam Mehrpooya
- PubMed: 35936217
- DOI: 10.1155/2022/2493053
- High evidence
- Clinical
the serum levels of proinflammatory biomarkers, including soluble intercellular adhesion molecule-1 (sICAM-1), interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α), and neuron-specific enolase (NSE), showed a significant decrease
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 1000 mg three times per day for three consecutive days